Two randomized clinical trials were harmonized to compare the effect of vitamin C vs control on outcomes in hospitalized patients with COVID-19 who were critica
Results from the COMBACTE-CARE project show that – if approved – a new combination of drugs could help in the fight against some of the most dangerous drug-resistant bacteria.
Bavarian Nordic, the manufacturer of the world’s only vaccine approved against Monkeypox, MVA-BN, has issued a third party license to the Shanghai based.
Marina Wainstein and colleagues examine acute kidney injury (AKI) incidence, severity, and outcomes among patients with COVID-19 using both a traditional and extended definition of AKI.